Literature DB >> 18272178

The fellowship of the RING: the RING-B-box linker region interacts with the RING in TRIM21/Ro52, contains a native autoantigenic epitope in Sjögren syndrome, and is an integral and conserved region in TRIM proteins.

Janosch Hennig1, Anders Bresell, Martina Sandberg, Klaus D M Hennig, Marie Wahren-Herlenius, Bengt Persson, Maria Sunnerhagen.   

Abstract

Ro52 is a major autoantigen that is targeted in the autoimmune disease Sjögren syndrome and belongs to the tripartite motif (TRIM) protein family. Disease-related antigenic epitopes are mainly found in the coiled-coil domain of Ro52, but one such epitope is located in the Zn(2+)-binding region, which comprises an N-terminal RING followed by a B-box, separated by a approximately 40-residue linker peptide. In the present study, we extend the structural, biophysical, and immunological knowledge of this RING-B-box linker (RBL) by employing an array of methods. Our bioinformatic investigations show that the RBL sequence motif is unique to TRIM proteins and can be classified into three distinct subtypes. The RBL regions of all three subtypes are as conserved as their known flanking domains, and all are predicted to comprise an amphipathic helix. This helix formation is confirmed by circular dichroism spectroscopy and is dependent on the presence of the RING. Immunological studies show that the RBL is part of a conformation-dependent epitope, and its antigenicity is likewise dependent on a structured RING domain. Recombinant Ro52 RING-RBL exists as a monomer in vitro, and binding of two Zn(2+) increases its stability. Regions stabilized by Zn(2+) binding are identified by limited proteolysis and matrix-assisted laser desorption/ionization mass spectrometry. Furthermore, the residues of the RING and linker that interact with each other are identified by analysis of protection patterns, which, together with bioinformatic and biophysical data, enabled us to propose a structural model of the RING-RBL based on modeling and docking experiments. Sequence similarities and evolutionary sequence patterns suggest that the results obtained from Ro52 are extendable to the entire TRIM protein family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272178     DOI: 10.1016/j.jmb.2008.01.005

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Determinants of the higher order association of the restriction factor TRIM5alpha and other tripartite motif (TRIM) proteins.

Authors:  Xing Li; Darwin F Yeung; Ann M Fiegen; Joseph Sodroski
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

2.  Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.

Authors:  Maritza Lienlaf; Fumiaki Hayashi; Francesca Di Nunzio; Naoya Tochio; Takanori Kigawa; Shigeyuki Yokoyama; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

3.  Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.

Authors:  Alexander Espinosa; Janosch Hennig; Aurélie Ambrosi; Madhanagopal Anandapadmanaban; Martina Sandberg Abelius; Yi Sheng; Filippa Nyberg; Cheryl H Arrowsmith; Maria Sunnerhagen; Marie Wahren-Herlenius
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

Review 4.  Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases.

Authors:  Liubov V Gushchina; Thomas A Kwiatkowski; Sayak Bhattacharya; Noah L Weisleder
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

5.  The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.

Authors:  S Brauner; M Ivanchenko; G E Thorlacius; A Ambrosi; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-10-16       Impact factor: 4.330

6.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

7.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.

Authors:  Felipe Diaz-Griffero; Xu-rong Qin; Fumiaki Hayashi; Takanori Kigawa; Andres Finzi; Zoe Sarnak; Maritza Lienlaf; Shigeyuki Yokoyama; Joseph Sodroski
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

9.  Induction of autoimmune response to the extracellular loop of the HERG channel pore induces QTc prolongation in guinea-pigs.

Authors:  Frank Fabris; Yuankun Yue; Yongxia Qu; Mohamed Chahine; Eric Sobie; Peng Lee; Rosemary Wieczorek; Xian-Cheng Jiang; Pier-Leopoldo Capecchi; Franco Laghi-Pasini; Pietro-Enea Lazzerini; Mohamed Boutjdir
Journal:  J Physiol       Date:  2016-07-26       Impact factor: 5.182

10.  Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.

Authors:  Ventzislava A Hristova; Steven A Beasley; R Jane Rylett; Gary S Shaw
Journal:  J Biol Chem       Date:  2009-04-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.